Caris (CAI) Director Joseph E. Gilliam Receives 13,192-Unit Award

What Happened Joseph E. Gilliam, a director of Caris Life Sciences, received an award of 13,192 restricted stock units (RSUs) on 2026-08-14. The grant is reported at $0.00 per share (aggregate value reported as $0 at grant) and is listed as an award/grant (transaction code A). This is a compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-14
• Transaction type/code: Award/Grant (A) — 13,192 RSUs
• Reported price: $0.00 per share; aggregate $0 at grant
• Shares owned after transaction: Not disclosed in the provided filing
• Footnote: F1 — award of restricted stock units that vest in accordance with the applicable grant agreement
• Filing timeliness: Reported and filed on 2026-08-14 (timely; Accession No. 0001705850-26-000025)

Context Restricted stock units represent a right to receive shares (or cash) in the future if and when they vest under the grant agreement. RSU grants are a form of equity compensation and do not necessarily indicate an insider buying or selling shares on the open market. Watch for future Form 4s when these RSUs vest and shares are delivered or when tax-withholding or sell-to-cover transactions occur, which can produce additional insider trading records.